Investors might be shocked to learn what lies behind the recent muscular share price growth of Freedom Holding Corp., a Las Vegas–incorporated bank and securities brokerage with its principal office in Almaty, Kazakhstan. Freedom Holding’s astronomical revenue growth has seemingly made it the fastest-growing financial services company on Earth.
Voluntary reports submitted to a Food and Drug Administration database, including entries from surgeons, paint a picture of a new Penumbra catheters whose safety problems the company may be forced to address in a substantive manner.
The U5 is one of the most important documents on Wall Street. And negotiations to discuss them can easily become a battleground where employers and employees fight over whether an upcoming exit will be classified as a resignation or a firing — and if problematic behavior is revealed.
For more than a decade Amy Walker, a research analyst in London, has been waging a ceaseless battle for justice in connection with what she alleges was a sexual assault by her colleague at Credit Suisse.
After five years of Fundamental Global Investors’ oversight, three public companies have weakened financially and their share prices have collapsed. Many minority investors in these three public companies, as well as the hedge fund’s limited partners, have absorbed steep losses.
Until late last year Dr. Quan Tran, a St. Petersburg, Florida, surgeon had an unusual side hustle. He served as one of three general partners of Q3 I LP, a cryptocurrency hedge fund that he helped launch in August 2017.
A high-profile research analyst who identifies and bets on troubled companies has acquired an unusual and perhaps unwarranted amount of influence in the brief period of time he’s been in this line of work.